Seminars in Nuclear Medicine

Article	Citations
Theranostics in Lung Neuroendocrine Tumors	192
Letter from the Editors	141
Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques	91
Non-FDG hypoxia tracers	83
Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update	76
FAPI-PET in Cardiovascular Disease	72
New Promising Targets for Imaging in Cardiovascular Diseases	71
New targets of PET imaging for renal cancer	63
PET/CT in the Imaging of CNS Tumors	56
The Value of FDG PET/CT in Penile Cancer: An Update	55
Sentinel Lymph Node Methods in Breast Cancer	54
Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies	50
Imaging of Invasive Fungal Infections- The Role of PET/CT	47
Autoimmune Thyroid Diseases	47
Prognostic Value of PSMA PET/CT in Prostate Cancer	45
Pediatric Nephro-Urology: Overview and Updates in Diuretic Renal Scans and Renal Cortical Scintigraphy	43
Letter from the Editors	42
The Role of Nuclear Medicine in Benign Thyroid Disease	42
Molecular Imaging in Inflammatory Bowel Disease	41
CD70-Targeted Radiotheranostics: Now and Future	41
Controversies in the Radioiodine Treatment of Patients With Differentiated Thyroid Cancer	41
Selective Internal Radiotherapy in Liver Tumors: Early Promise Yet to be Fulfilled	41
Artificial Intelligence for Drug Discovery: An Update and Future Prospects	40
Imaging for Radiation Planning in Breast Cancer	39
Imaging trends in diabetic foot infections	38

The evolving role of nuclear medicine in osteomyelitis: A narrative review of current evidence and future horizons	37
Emerging Trends in Radionuclide Imaging of Infection and Inflammation in Pediatrics: Focus on FDG PET/CT and Immune Reactivity	34
Radionuclide Imaging of Cardiac Amyloidosis: An Update and Future Aspects	34
The Evolution of Artificial Intelligence in Nuclear Medicine	33
PET-CT radiomics for immunotherapy response	32
Total-Body PET/CT: A Role of Artificial Intelligence?	32
Global experience in brain amyloid imaging	31
Current and Future Perspective of PET/CT in Response Assessment of Malignant Pleural Mesothelioma	31
New Approaches for Imaging Bacteria	29
PET/MR Technology: Advancement and Challenges	29
Artificial intelligence for tumor [18F]FDG-PET imaging: Advancement and future trends—part I	29
The Role of 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT) in the Diagnosis and Evaluation of Spondylodiscitis	28
Imaging of Cardiac Sarcoidosis: An Update and Future Aspects	28
The value of PSMA PET for risk stratification in prostate cancer: an update and future aspects	28
18F-Fluoride PET/CT—Updates	27
Expanding Role for Gallium-68 PET Imaging in Oncology	27
Total-body PET/CT – First Clinical Experiences and Future Perspectives	26
Use of Radionuclide-Based Imaging Methods in Breast Cancer	26
Renography: Methods and Pitfalls	26
Letter From the Editors	25
Update on Pediatric Nuclear Medicine in Acute Care	25
Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology	25
The Clinical Impact of FAPI PET Imaging: HCC, CCC, CUP & Peritoneal Carcinoma	24
Standardized PSMA-PET Imaging of Advanced Prostate Cancer	23
Future Imaging of Prostate Cancer: Do We Need More Than PSMA PET/CT?	23
Scintigraphic Diagnosis of Acute Pulmonary Embolism: From Basics to Best Practices	23
Fibroblast Activation Protein Inhibitor (FAPI) PET Imaging in Sarcomas: A New Frontier in Nuclear Medicine	23
Radiolabeled Somatostatin Analogs for Cancer Imaging	22
Practical approach to diuretic renography in children: Techniques, interpretation, and pitfalls	22
18F-Sodium Fluoride PET/CT in Assessing Valvular Heart and Atherosclerotic Diseases	22
Recent Advances and Future Trends of[18F]-Labeled PET Agents for Renal Imaging	22
Nuclear Medicine Preclinical Research: The Role of Cell Cultures	21
Practice of 18F-FDG-PET/CT in ICU Patients: A Systematic Review	21
FAPI PET Versus FDG PET/CT in Gastrointestinal Cancers: An Overview	21
Therapy strategies to defeat prostate cancer heterogeneity	21
The Clinical Utility of Molecular Imaging in COVID-19: An Update	20
Letter from the Editors	20
Advances in PET Imaging of Large Vessel Vasculitis: An Update and Future Trends	20
FDG PET/CT for Staging Lung Carcinoma: An Update	20
Optimizing CT Imaging Parameters: Implications for Diagnostic Accuracy in Nuclear Medicine	20
Artificial Intelligence Augmented Cerebral Nuclear Imaging	20
Functional Imaging of Testicular Torsion	20
Targeted Radiopharmaceutical Therapy for Bone Metastases	20
Nonmalignant findings on FAPI PET: An updated rapid systematic review of the literature	20
Development of PSMA-Targeted Alpha Therapy Using [211At]PSMA-5	19
The role of nuclear medicine in abdominopelvic infections	19
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma	19
Academic integrity and artificial intelligence: is ChatGPT hype, hero or heresy?	19
Molecular Imaging for Response Assessment of Neuroendocrine Tumors (NET)	18
Sentinel Node Mapping in Penile Cancer: An Update on Methods and Pitfalls	18

Total-Body PET/CT Metabolic Response in Esophageal Squamous Cell Carcinoma	18
A Role of Non-FDG Tracers in Lung Cancer?	18
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers Part II. [F]F-FLT, [F]F-FET, [C]C-MET and Other Less-Commonly Used Radiotrace	18
Molecular Imaging in Soft-tissue Sarcoma: Evolving Role of FDG PET	18
Artificial Intelligence and Workforce Diversity in Nuclear Medicine	18
Prostate Cancer Theranostics With 177Lu-PSMA	17
Radiomolecular Theranostics With Fibroblast-Activation-Protein Inhibitors and Peptides	17
RETRACTED: Radiotracing the Future: Non-FDG Radiotracers Nuclear Medicine	17
Radiomics and Artificial Intelligence Landscape for [18F]FDG PET/CT in Multiple Myeloma	17
Letter From the Editors	16
Hybrid Imaging: Calcium Score and Myocardial Perfusion Imaging	16
Response Evaluation Criteria in Grade 1/2 Neuroendocrine Tumors (RECIN)	16
Radiolabeled Antibody–Drug Conjugates in the Treatment of Solid Tumors	16
Advances and challenges of PET imaging in bladder cancer–An update and future trends	16
Letter From the Guest Editors	16
Neuroimaging of Mild Traumatic Injury	16
Infection and Inflammation in Nuclear Medicine Imaging: The Role of Artificial Intelligence	15
A Practical Guide to the Pearls and Pitfalls of PSMA PET Imaging	15
Letter from the Editors	15
How to Perform FAPI PET? An Expedited Systematic Review Providing a Recommendation for FAPI PET Imaging With Different FAPI Tracers	15
Current Developments on [18F]FDG PET/CT in Inflammatory Disorders of the Central Nervous System	15
Cardiac PET/MRI: Recent Developments and Future Aspects	15
Advances in PET/CT Technology: An Update	15
Letter from the Editors	14
Total Body PET/CT: A Role in Musculoskeletal Diseases	14
Letter from the Editors	14
Preclinical Evaluation of Novel PET Probes for Dementia	14
Cardiovascular Imaging in Women	14
PET/CT Assessment of Estrogen Receptor positivity for Breast Cancer using [68Ga]Ga-RM2 Bombesin Receptor Antagonist: A Systematic Review and Meta-Analysis	13
SPECT/CT, PET/CT, and PET/MRI for Response Assessment of Bone Metastases	13
Towards a More Inclusive Future: A Comprehensive Assessment of Gender Diversity in Nuclear Medicine Education, Training and Workforce	13
Letter From the Editors	13
Parathyroid Imaging	13
Response assessment in advanced differentiated thyroid cancer	13
Advances of PET/CT in Target Delineation of Lung Cancer Before Radiation Therapy	13
Copper-64 Based PET-Radiopharmaceuticals: Ways to Clinical Translational	13
Letter from the Editors	12
Current status on imaging invasive fungal infections with positron emission tomography	12
Insights into the Global Practice of Paediatric Renal Scintigraphy Studies	12
New Targets for Imaging in Nuclear Medicine	12
Glypican-3: Novel Theranostic Agent for Hepatocellular Carcinoma	12
Long Axial Field-of-View PET/CT: New Opportunities for Pediatric Imaging	12
The Value of Artificial Intelligence in Prostate-Specific Membrane Antigen Positron Emission Tomography: An Update	12
Diagnosing Bone Metastases in Breast Cancer: A Systematic Review and Network Meta-Analysis on Diagnostic Test Accuracy Studies of 2-[18F]FDG-PET/CT, 18F-NaF-PET/CT, MRI, Contrast-Enhanced CT, and Bone	12
Hepato-Biliary Imaging in an Acute Setting: Is There a Role for Nuclear Medicine?	12
Advancement and Future Perspective of FAPI PET/CT In Gynecological Malignancies	12
Radiopharmaceuticals for imaging T-cells	12
New PET Tracers: Current Knowledge and Perspectives in Lung Cancer	12
FDG PET/CT for Staging and Restaging Malignant Mesothelioma	12
Pitfalls of Radionuclide Renal Imaging in Pediatrics	12
Current and Future Perspectives of PDL1 PET and SPECT Imaging	11
AI in SPECT Imaging: Opportunities and Challenges	11
Imaging of Endocarditis and Cardiac Device-Related Infections: An Update	11
The Value of FAPI PET/CT in Cholangiocarcinoma and Pancreatic Cancer: An Update	11
The Past, Present, and Future Role of Artificial Intelligence in Ventilation/Perfusion Scintigraphy: A Systematic Review	11
New Targets for Positron Emission Tomography Imaging in Parkinson´s Disease	11
PET imaging of polymyalgia rheumatica: update and future trends	11
Imaging of infection in Nephro-urology: A practical nuclear medicine–focused review	11
Molecular imaging Theranostics of Neuroendocrine Tumors	11
Application of Artificial Intelligence in Oncologic Molecular PET-Imaging: A Narrative Review on Beyond [18F]F-FDG Tracers - Part I. PSMA, Choline, and DOTA Radiotracers	10
Imaging of Bone Metastases in Breast Cancer	10
Letter from the Editors	10
Implementation of Radiotheranostics: Challenges, Barriers, and IAEA-Driven Strategies for Sustainable Access	10
Letter from the Editors	10
Advancement in Production of Radiotracers	9
The Rebirth of Radioimmunotherapy of Non-Hodgkin Lymphoma: The Phoenix of Nuclear Medicine?	9
Letter From the Editors	9
Combination Strategies and Targeted Radionuclide Therapies	9
Imaging Approach to Disease of the Pleura	9
Standardization of infection [18F]FDG-PET/CT imaging protocols and reporting criteria	9
Application of Deep Learning in Breast Cancer Imaging	9
Critical Appraisal of the Current Role of Myocardial Perfusion Imaging in the Management of Acute Chest Pain	9
Quantification, radiomics and artificial intelligence in infection imaging: Current status and future directions in nuclear medicine	9
Preclinical Development in Radiopharmaceutical Therapy for Prostate Cancer	9
Advances in PSMA Alpha Theragnostics	9
The Role of FDG-PET and Whole-Body MRI in High Grade Bone Sarcomas With Particular Focus on Osteosarcoma	9
FDG PET/CT Imaging of Sarcoidosis	9
Letter From the Editors	8
Re-defining the 3Rs of pre-clinical research in nuclear medicine	8
Long Axial Field-of-View (LAFOV) PET/CT in Prostate Cancer	8

FDG-PET/CT for Primary Staging and Detection of Recurrence of Breast Cancer	8
Diagnostic Value of Gastrin-Releasing Peptide Receptor-Targeted PET Imaging in Oncology: A Systematic Review	8
The Current Role of Tau PET Imaging in Neurodegeneration	8
Bone Metastasis in Prostate Cancer: Bone Scan Versus PET Imaging	8
Clinical Use of PET/MR in Oncology: An Update	8
Artificial Intelligence in Nuclear Cardiology: An Update and Future Trends	8
Preclinical Imaging Studies: Protocols, Preparation, Anesthesia, and Animal Care	8
Role of Artificial Intelligence in PET/CT Imaging for Management of Lymphoma	8
The Role of FAPI PET/CT in the Assessment of Inflammatory Diseases	7
Updates on tuberculosis imaging	7
Molecular Imaging of Fever of Unknown Origin: An Update	7
The Impact of Radiopharmaceutical Therapy on Renal Function	7
18F-FDG PET/CT for Response Assessment in Lung Cancer	7
The Role of [18F]FDG PET/CT in Monitoring of Therapy Response in Lung Cancer	7
FAP in cardiovascular pathophysiology: Advances in non-invasive imaging and therapeutic targeting for myocardial fibrosis	7
New targets for PET imaging of inflammation	7
PET/CT in Bladder Cancer: An Update	7
Clinical Value of FDG-PET/CT in Multiple Myeloma: An Update	7
Total Body PET-CT Protocols in Oncology	7
A Role for PET/CT in Response Assessment of Malignant Pleural Mesothelioma	7
Vulnerable Plaque Imaging	7
Molecular Imaging of Tuberculosis	7
Diuretic Renal Scintigraphy in Adults: Practical Aspects and Reporting	7
The Role of AI in the Evaluation of Neuroendocrine Tumors: Current State of the Art	7
Clinical implementation of RECIP 1.0	7
Renal Scintigraphy in Adults: An Update	7